Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study
| Autor: | Fleischhacker, W Wolfgang, Podhorna, Jana *, Gröschl, Martina, Hake, Sanjay, Zhao, Yihua, Huang, Songqiao, Keefe, Richard S E, Desch, Michael, Brenner, Ronald, Walling, David P, Mantero-Atienza, Emilio, Nakagome, Kazuyuki, Pollentier, Stephane |
|---|---|
| Zdroj: | In The Lancet Psychiatry March 2021 8(3):191-201 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|